Vaso Corp

OTC: VASO    
Share price (4/19/24): $0.29    
Market cap (4/19/24): $54.7 million

Material Contracts Filter

EX-10.6
from 8-K 20 pages Company Support Agreement
12/34/56
EX-10.5
from 8-K 11 pages Indemnification Agreement
12/34/56
EX-10.4
from 8-K 4 pages Lock-Up Agreement
12/34/56
EX-10.3
from 8-K 18 pages Form of Amended and Restated Registration Rights Agreement
12/34/56
EX-10.2
from 8-K 26 pages Put Option Agreement
12/34/56
EX-10.1
from 8-K 5 pages Reference Is Made to That Certain Business Combination Agreement (The “Bca”), Dated as of December 6, 2023, by and Among Achari Ventures Holdings Corp. I., a Delaware Corporation (“Spac”), Achari Merger Sub Inc., a Delaware Corporation and Wholly Owned Direct Subsidiary of Spac (“Merger Sub”) and Vaso Corporation, a Delaware Corporation (The “Company”). This Letter Agreement (This “Letter Agreement”) Is Being Entered Into and Delivered by Spac, the Company, Achari Sponsor Holdings I LLC, a Delaware Limited Liability Company (The “Sponsor”) and the Additional Undersigned Individuals, Each of Whom Is a Member of the Spac’s Board of Directors and/or the Management Team of the Spac (Each, an “Insider” and Collectively, the “Insiders”), in Connection With the Transactions Contemplated by the Bca. Capitalized Terms Used but Not Otherwise Defined Herein Shall Have the Meanings Ascribed to Such Terms in the Bca. in Consideration of the Foregoing and for Other Good and Valuable Consideration, the Receipt and Sufficiency of Which Are Hereby Acknowledged, Spac, the Company, the Sponsor and the Insiders Hereby Agree as Follows
12/34/56
EX-10
from 10-K 6 pages Vaso Corporation 2019 Stock Plan I. General Provisions
12/34/56
EX-10
from 10-Q 7 pages Vasomedical, Inc. 2016 Stock Plan I. General Provisions
12/34/56
EX-10
from 8-K 16 pages Employment Agreement
12/34/56
EX-10.2
from 8-K 19 pages Subordinated Security Agreement
12/34/56
EX-10.1
from 8-K 25 pages Asset Purchase and Sale Agreement Between Vasomedical, Inc. and Vasotechnology, Inc. and Netwolves, LLC and Netwolves Corporation May 29, 2015
12/34/56
EX-10
from 10-Q Material contract
12/34/56
EX-10
from 10-Q 1 page Please Refer to File: Vaso10q-June2014ex10.pdf
12/34/56
EX-10
from 10-Q 11 pages Vasomedical, Inc. 2013 Stock Plan
12/34/56
EX-10
from 10-K 16 pages Employment Agreement
12/34/56
EX-10
from 8-K 5 pages Fifth Amendment to Sales Representative Agreement
12/34/56
EX-10
from 10-K 46 pages Stock Purchase Agreement Among the Shareholders of Fast Growth Enterprises Limited as Sellers and Vasomedical Acquisition Corp. as Purchaser for the Purchase of All of the Outstanding Capital Stock of Fast Growth Enterprises Limited Dated as of August 19, 2011
12/34/56
EX-10
from 8-K 16 pages Employment Agreement
12/34/56
EX-10
from 8-K/A 51 pages Sales Representative Agreement
12/34/56
EX-10.(M)
from 10-K 12 pages Vasomedical, Inc. 2010 Stock Plan I. General Provisions
12/34/56